Import of pharmaceutical products surged by 276% to US$4.36 billion last year, mainly because of Covid-19 related medicines, medical equipments, and vaccines. Even if the pandemic is over, the country’s import of pharmaceuticals will continue to grow. It is understandable if the government has been pushing for more import-substitution investment in the sector. To subscribe please click here
